Literature DB >> 29671869

Regulation of vascular permeability in anaphylaxis.

Tatsuro Nakamura1, Takahisa Murata1.   

Abstract

Anaphylaxis is a life-threatening type I allergic reaction. Antigen-antibody complexes induce mast cells, basophils and neutrophils to release large amounts of histamine and/or PAF. These mediators induce hypotension and vascular hyper-permeability and subsequent anaphylaxis dependent on the endothelial production of NO. Here, we have summarized previous studies reporting the mechanisms underlying the functional changes within the vasculature, specifically focusing on vascular permeability triggered by histamine or PAF. In addition to these pro-inflammatory factors, PGD2 is abundantly released in anaphylaxis, mainly from mast cells. We recently demonstrated that mast cell-derived PGD2 attenuates anaphylactic responses by inhibiting vascular hyper-permeability in mouse models. Our findings suggest that pro- and anti-inflammatory factors concurrently regulate vascular permeability in anaphylaxis. In this mini-review, we discuss the multifactorial mechanisms underlying vascular hyper-permeability in anaphylaxis.
© 2018 The British Pharmacological Society.

Entities:  

Mesh:

Year:  2018        PMID: 29671869      PMCID: PMC6003654          DOI: 10.1111/bph.14332

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.

Authors:  Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

Review 2.  Regulation of vascular permeability in anaphylaxis.

Authors:  Tatsuro Nakamura; Takahisa Murata
Journal:  Br J Pharmacol       Date:  2018-05-22       Impact factor: 8.739

3.  Biologic properties of LTB4 and paf-acether in vivo in human skin.

Authors:  L Michel; J M Mencia-Huerta; J Benveniste; L Dubertret
Journal:  J Invest Dermatol       Date:  1987-06       Impact factor: 8.551

4.  Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis.

Authors:  I Miyajima; D Dombrowicz; T R Martin; J V Ravetch; J P Kinet; S J Galli
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

5.  Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions.

Authors:  Katherine Arias; Moiz Baig; Marc Colangelo; Derek Chu; Tina Walker; Susanna Goncharova; Anthony Coyle; Peter Vadas; Susan Waserman; Manel Jordana
Journal:  J Allergy Clin Immunol       Date:  2009-05-05       Impact factor: 10.793

6.  Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability.

Authors:  Fabiola A Sánchez; Roshniben Rana; David D Kim; Toru Iwahashi; Ruifang Zheng; Brajesh K Lal; Donna M Gordon; Cynthia J Meininger; Walter N Durán
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-02       Impact factor: 11.205

7.  Nitric oxide accounts for histamine-induced increases in macromolecular extravasation.

Authors:  W G Mayhan
Journal:  Am J Physiol       Date:  1994-06

8.  RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock.

Authors:  Constantinos M Mikelis; May Simaan; Koji Ando; Shigetomo Fukuhara; Atsuko Sakurai; Panomwat Amornphimoltham; Andrius Masedunskas; Roberto Weigert; Triantafyllos Chavakis; Ralf H Adams; Stefan Offermanns; Naoki Mochizuki; Yi Zheng; J Silvio Gutkind
Journal:  Nat Commun       Date:  2015-04-10       Impact factor: 14.919

9.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

10.  Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells.

Authors:  S Esser; M G Lampugnani; M Corada; E Dejana; W Risau
Journal:  J Cell Sci       Date:  1998-07       Impact factor: 5.285

View more
  14 in total

1.  P53 supports endothelial barrier function via APE1/Ref1 suppression.

Authors:  Mohammad A Uddin; Mohammad S Akhter; Agnieszka Siejka; John D Catravas; Nektarios Barabutis
Journal:  Immunobiology       Date:  2019-04-18       Impact factor: 3.144

Review 2.  Regulation of vascular permeability in anaphylaxis.

Authors:  Tatsuro Nakamura; Takahisa Murata
Journal:  Br J Pharmacol       Date:  2018-05-22       Impact factor: 8.739

Review 3.  Mast Cell Activation Syndrome in COVID-19 and Female Reproductive Function: Theoretical Background vs. Accumulating Clinical Evidence.

Authors:  Dariusz Szukiewicz; Piotr Wojdasiewicz; Mateusz Watroba; Grzegorz Szewczyk
Journal:  J Immunol Res       Date:  2022-06-22       Impact factor: 4.493

Review 4.  Mast Cell and Basophil Granule Proteases - In Vivo Targets and Function.

Authors:  Lars Hellman; Srinivas Akula; Zhirong Fu; Sara Wernersson
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

5.  A natural mouse model reveals genetic determinants of systemic capillary leak syndrome (Clarkson disease).

Authors:  Abbas Raza; Zhihui Xie; Eunice C Chan; Wei-Sheng Chen; Linda M Scott; A Robin Eisch; Dimitry N Krementsov; Helene F Rosenberg; Samir M Parikh; Elizabeth P Blankenhorn; Cory Teuscher; Kirk M Druey
Journal:  Commun Biol       Date:  2019-10-31

6.  In Vitro Investigation of Vascular Permeability in Endothelial Cells from Human Artery, Vein and Lung Microvessels at Steady-State and Anaphylactic Conditions.

Authors:  Katrine T Callesen; Alma Yuste-Montalvo; Lars K Poulsen; Bettina M Jensen; Vanesa Esteban
Journal:  Biomedicines       Date:  2021-04-19

7.  Should steroids be used for anaphylaxis after the COVID-19 vaccine?

Authors:  Youngho Seo; Taekyu Ahn; Jinhui Paik; Soo Kang
Journal:  Clin Exp Emerg Med       Date:  2021-12-31

8.  Diagnosing capillary leak in critically ill patients: development of an innovative scoring instrument for non-invasive detection.

Authors:  Jakob Wollborn; Lars O Hassenzahl; Daniel Reker; Hans Felix Staehle; Anne Marie Omlor; Wolfgang Baar; Kai B Kaufmann; Felix Ulbrich; Christian Wunder; Stefan Utzolino; Hartmut Buerkle; Johannes Kalbhenn; Sebastian Heinrich; Ulrich Goebel
Journal:  Ann Intensive Care       Date:  2021-12-15       Impact factor: 6.925

9.  Penicillin causes non-allergic anaphylaxis by activating the contact system.

Authors:  Yuan Gao; Yixin Han; Xiaoyu Zhang; Qiaoling Fei; Ruijuan Qi; Rui Hou; Runlan Cai; Cheng Peng; Yun Qi
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

10.  Proteomic and Biological Analysis of an In Vitro Human Endothelial System in Response to Drug Anaphylaxis.

Authors:  Alma Yuste-Montalvo; Sergio Fernandez-Bravo; Tamara Oliva; Carlos Pastor-Vargas; Diana Betancor; María José Goikoetxea; José Julio Laguna; Juan Antonio López; Gloria Alvarez-Llamas; Javier Cuesta-Herranz; Marta Martin-Lorenzo; Vanesa Esteban
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.